Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling

Peter R. Shepherd(Institute of Structural and Molecular Biology), Dominic J. Withers(Joslin Diabetes Center), Kenneth Siddle(Addenbrooke's Hospital)
Biochemical Journal
August 1, 1998
Cited by 958Open Access
Full Text

Abstract

Insulin plays a key role in regulating a wide range of cellular processes. However, until recently little was known about the signalling pathways that are involved in linking the insulin receptor with downstream responses. It is now apparent that the activation of class 1a phosphoinositide 3-kinase (PI 3-kinase) is necessary and in some cases sufficient to elicit many of insulin's effects on glucose and lipid metabolism. The lipid products of PI 3-kinase act as both membrane anchors and allosteric regulators, serving to localize and activate downstream enzymes and their protein substrates. One of the major ways these lipid products of PI 3-kinase act in insulin signalling is by binding to pleckstrin homology (PH) domains of phosphoinositide-dependent protein kinase (PDK) and protein kinase B (PKB) and in the process regulating the phosphorylation of PKB by PDK. Using mechanisms such as this, PI 3-kinase is able to act as a molecular switch to regulate the activity of serine/threonine-specific kinase cascades important in mediating insulin's effects on endpoint responses.


Related Papers

No related papers found

Powered by citation graph analysis